top of page

Regulatory Updates

View Profile

New PMS Obligations for Medical Devices in Great Britain (2024)

The Medical Devices Regulations 2024 introduce new post-market surveillance obligations for manufacturers in Great Britain. A summary of the new Part 4A requirements and timelines.

Date

16. Jänner 2025

Tag

Regulatory Updates

Share

The ???????????????????????????? ???????????????????????????? (????????????????-???????????????????????? ???????????????????????????????????????????????? ????????????????????????????????????????????????) (????????????????????????????????????) (???????????????????? ????????????????????????????) ???????????????????????????????????????????? ???????????????? introduce new post-market surveillance (PMS) obligations for medical device manufacturers in Great Britain by adding Part 4A, which outlines requirements for monitoring device performance and safety after market introduction.


???????????? ???????????????????????????????????????? ????????????????????????????:

???????????? ???????????????????????? ???????????? ????????????????: Manufacturers must establish a PMS system and develop a detailed plan for ongoing monitoring of their devices.


???????????????????????????????? ????????????????????????????????????: Obligations are set for reporting serious incidents and trends, with specific timelines for initial and final reports.


???????????????????????????????????????? ???????????? ???????????????????????????????????????? ????????????????????????????: Manufacturers are required to implement measures to address potential or actual non-conformities, including field safety corrective actions.


???????????????????????????????????????????????????? ????????????????????????????????????: Manufacturers must retain relevant documentation for a specified period to ensure traceability and accountability.


These measures aim to enhance patient safety by ensuring continuous monitoring and prompt action regarding medical devices post-market.


???????????????? 4???? of The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024: https://www.legislation.gov.uk/uksi/2024/1368/regulation/4/made


???????????????????????????????? of The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024: https://www.gov.uk/government/publications/medical-devices-post-market-surveillance-requirements/the-medical-devices-post-market-surveillance-requirements-amendment-great-britain-regulations-2024-guidance-on-implementation

KEY TAKEAWAY

New Post-Market Surveillance Obligations in Great Britain

The Medical Devices Regulations 2024 add Part 4A, introducing new post-market surveillance obligations for medical device manufacturers in Great Britain. Manufacturers must establish a PMS system and a detailed monitoring plan, report serious incidents and trends within specific timelines, implement corrective measures including field safety corrective actions for non-conformities, and retain documentation for traceability and accountability.

New Post-Market Surveillance Obligations in Great Britain

The Medical Devices Regulations 2024 add Part 4A, introducing new post-market surveillance obligations for medical device manufacturers in Great Britain. Manufacturers must establish a PMS system and a detailed monitoring plan, report serious incidents and trends within specific timelines, implement corrective measures including field safety corrective actions for non-conformities, and retain documentation for traceability and accountability.

RELATED ARTICLES

usgs-T72rrSoh-Yo-unsplash.jpg

New MHRA Guidance on Digital Mental Health Technologies (DMHT)

Regulatory Updates

5. Februar 2025

usgs-T72rrSoh-Yo-unsplash.jpg

MHRA Update: Nanomedicine Decision Tree Released

Regulatory Updates

5. Februar 2025

bottom of page